Genetix Acquires SlidePath | GenomeWeb

NEW YORK (GenomeWeb News) – Genetix today announced that it has acquired analysis and data management software firm SlidePath for undisclosed consideration.

Genetix said that the acquisition will complement its offerings in the digital pathology market. Specifically, the Hampshire, UK-based firm said that SlidePath's products will complement its Ariol platform, which is a digital imaging and analysis solution for quantifying biomarkers in tissue sections and tissue microarrays.

SlidePath will continue to operate from its headquarters in Dublin, Ireland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.